Patent Sublicense AgreementPatent Sublicense Agreement • October 9th, 2018 • Moderna, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledOctober 9th, 2018 Company Industry JurisdictionThis Patent Sublicense Agreement (“Agreement”) is between CELLSCRIPT, LLC, a Wisconsin limited liability company having a place of business at 726 Post Road, Madison, WI 53713, USA (“Cellscript”) and ModernaTx, Inc., a Delaware corporation having a place of business at 320 Bent Street, Cambridge, MA 02141, USA (“Company”). This Agreement is effective as of June 26, 2017 (the “Effective Date”). Each of Company and Cellscript are referred to herein as a “Party” and collectively as the “Parties”.
Patent Sublicense AgreementPatent Sublicense Agreement • August 30th, 2018 • Moderna, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledAugust 30th, 2018 Company Industry JurisdictionThis Patent Sublicense Agreement (“Agreement”) is between CELLSCRIPT, LLC, a Wisconsin limited liability company having a place of business at 726 Post Road, Madison, WI 53713, USA (“Cellscript”) and ModernaTx, Inc., a Delaware corporation having a place of business at 320 Bent Street, Cambridge, MA 02141, USA (“Company”). This Agreement is effective as of June 26, 2017 (the “Effective Date”). Each of Company and Cellscript are referred to herein as a “Party” and collectively as the “Parties”.